Drug-eluting stents and vulnerable plaque
Tóm tắt
Coronary artery disease with acute coronary syndromes (ACS) is the leading cause of death worldwide in both men and women. ACS mostly occur as a result of rupture of “vulnerable plaque” with a superimposed thrombus formation, which ultimately leads to distal cessation of blood flow. Vulnerable plaque mostly occurs in mildly obstructive coronary lesions rather than severely stenosed (< 50%) lesions. Support for this conclusion comes from studies of patients with ACS who had a recent prior coronary angiogram; the artery involved in the subsequent ACS was usually only moderately diseased. Whether early treatment of these mildly obstructive lesions with percutaneous coronary interventions may lead to prevention of this deadly malady remains unknown. The long-term efficacy of percutaneous coronary intervention for mildly obstructive coronary narrowing is limited by the occurrence of restenosis, which limits the applicability of this therapy for these lesions. However, use of drug-eluting stents has significantly reduced the incidence of in-stent restenosis, yielding much better long-term outcomes. This article reviews the available data for possible early treatment of mildly obstructive coronary lesions with drug-eluting stents for prevention of ACS.
Tài liệu tham khảo
Fuster V, Fayad ZA, Badimon JJ: Acute coronary syndromes: biology. Lancet 1999, 353(Suppl 2):SII5–9.
Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995, 92:657–671.
Ambrose JA, Tannenbaum MA, Alexopoulos D, et al.: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988, 12:56–62.
Burke AP, Kolodgie FD, Farb A, et al.: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001, 103:934–940.
Virmani R, Kolodgie FD, Burke AP, et al.: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262–1275.
Arbustini E, Dal Bello B, Morbini P, et al.: Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999, 82:269–272.
Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135–1143.
Mercado N, Maier W, Boersma E, et al.: Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 2003, 24:541–551.
Farb A, Weber DK, Kolodgie FD, et al.: Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002, 105:2974–2980.
Lemos PA, Lee CH, Degertekin M, et al.: Early outcome after sirolimus eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2003, 41:2093–2099.
Lemos PA, Serruys PW, Van Domburg R, et al.: Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world.” The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004, 109:190–195.
Hoye A, Lemos P, Chourmouzios AA, et al.: Effectiveness of sirolimus-eluting stent implantation for coronary narrowings < 50% in diameter. Am J Cardiol 2004, 94:112–114.
Barlis P, Serruys PW, Gonzalo N, et al.: Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am J Cardiol 2008, 102:391–395.
Takarada S, Imanishi T, Kubo T, et al.: Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 2008, May 15 [Epub ahead of print].